Microemulsion Core-Shell Quantum Dots for Cadmium-Free NIR Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biomedical imaging techniques using near-infrared (NIR) fluorophores often rely on cadmium-based quantum dots, which raise toxicity concerns, and lack precise control over size, size distribution, and composition, affecting fluorescence spectrum and application in medical diagnostics and therapies.
Innovation Solution
Development of cadmium-free near-infrared core-shell quantum dots based on I-III-VI ternary semiconductors, such as CuInS2 and AgInS2 cores coated with ZnS or ZnSe shells, synthesized using a microemulsion template approach to control size, composition, and fluorescence emission, enabling biocompatibility and precise control over NIR emission.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cadmium-based quantum dots are used for NIR fluorescence imaging, then fluorescence intensity and photostability are improved, but toxicity increases making them unsuitable for biomedical applications
Solution Approach 1:
The patent changes the compositional parameters of quantum dots by replacing cadmium with non-toxic elements (Cu, Ag, In, Ga, Zn, S, Se, Te) while maintaining the desired fluorescence properties through careful selection of element combinations and ratios in I-II-VI and I-III-VI ternary semiconductors
Solution Approach 2:
The patent employs composite material structures including core-shell quantum dots (e.g., CuInS2 core with ZnS shell) and alloyed semiconductors (e.g., Cu(In,Ga)S2) that combine the advantages of different materials to achieve high fluorescence performance without cadmium toxicity
2Ease of manufacture
If conventional synthesis methods are used for quantum dots, then production is simpler, but control over size, size distribution, and composition is insufficient affecting fluorescence spectrum precision
Solution Approach 1:
The patent segments the synthesis process into distinct stages: microemulsion template formation, nucleation within droplets, growth phase, and shell formation. This segmentation allows independent optimization of each stage to achieve precise control over quantum dot properties while maintaining processability
Solution Approach 2:
The patent introduces microemulsion templates as an intermediary system during synthesis. The surfactant-based microemulsion droplets act as nanoreactors that confine and control the nucleation and growth of quantum dots, enabling precise size and composition control through template parameters rather than direct complex synthesis conditions
3Manufacturing precision
If core-shell structure is implemented with multiple growth stages, then control over size and composition is improved, but synthesis process complexity increases
Solution Approach 1:
The patent performs preliminary actions by pre-forming microemulsion templates with controlled size and composition before introducing precursors. The templates are prepared in advance with specific surfactant concentrations and droplet sizes, which predetermined the final quantum dot dimensions and reduce the complexity of the actual nucleation and growth steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The synthesized quantum dots exhibit high fluorescence intensity, quantum yield, and photostability, are biocompatible, and offer precise control over size and composition, making them suitable for biomedical applications without the toxicity of cadmium.
Implementation Method 1
A microemulsion template assisted approach to nucleation and growth of the cores is used
Implementation Method 2
thermally annealing the core-shell nanoparticles
Implementation Method 3
These quantum dots are biocompatible and fluoresce in the near infrared (NIR), e.g., with fluorescence emission wavelengths in the range of 650 to 840 nm
Data Source
AI summary
A method for making ternary core-shell semiconductor nanoparticles includes providing an emulsion including droplets dispersed in a continuous phase of a non-polar solvent. The droplets include a solution of ions of a Group I element and ions of a Group III element in a polar solvent, and are encapsulated by an interfacially active material. The emulsion is exposed to ions of a Group VI element to cause a reaction, thereby forming nanoparticles in the droplets. The nanoparticles in the droplets are with a first precursor to grow a shell on the nanoparticles, thereby forming core-shell nanoparticles. The core-shell nanoparticles are extracted from the emulsion; thermally annealed; and reacted with a second precursor to further grow the shell on the nanoparticles, thereby forming ternary core-shell semiconductor nanoparticles.